Experienced in Primary Hyperoxaluria

Nathalie Demoulin

Brussels, BRU, BE 
Experienced in Primary Hyperoxaluria
Brussels, BRU, BE 
OverviewLocationsClinical Research

Overview

Nathalie Demoulin practices in Brussels, Belgium. Ms. Demoulin is rated as an Experienced expert by MediFind in the treatment of Primary Hyperoxaluria. Her top areas of expertise are Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Glomerulonephritis, Goodpasture Syndrome, and Kidney Transplant.

Her clinical research consists of co-authoring 56 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Primary Hyperoxaluria.

Gender
Female

Locations

Brussels, BRU, Belgium
Other Locations
Charleroi, WAL, Belgium
Leuven, VLG 1348, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
View 1 Less Clinical Trial

56 Total Publications

Predicting prognosis in ANCA-associated vasculitis with kidney involvement.
Predicting prognosis in ANCA-associated vasculitis with kidney involvement.
Journal: Clinical kidney journal
Published: April 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Demoulin's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile